Full-text search across primary regulatory records, analytical lab audits, and evidence-led pharmacology guides.
News WireThe July 23 PCAC vote recommended six peptides for human compounding despite career scientists citing absent safety data. The decision amplified demand across informal markets, including pet-care channels where no dosing evidence exists.
News WireOn August 12, 2026, Eli Lilly sued Aesthetic Envy, Astra, and four other entities over alleged illegal sales of its investigational obesity drug retatrutide. The company has referred over 200 entities to regulators and flagged 14,000.
News WireFourteen outside advisers split 8-6 to recommend six injectable peptides for compounding pharmacy access, rejecting FDA staff warnings that none has passed rigorous human trials. The non-binding vote aligns with Health Secretary RFK Jr.'s.
News WireThe FDA's advisory committee voted narrowly to recommend six popular peptides for compounding, overruling agency scientists who cited a lack of human safety data. The vote is a nonbinding recommendation that must survive formal rulemaking.
News WireEli Lilly filed six federal lawsuits on August 12, 2026, against Aesthetic Envy, Astra, Legendary Peptides, Striker Pharmacy, Texas Peptides, and Lone Star Peptide. The complaints allege these businesses sold illegal versions of.
GuideGHRP-2 and GHRP-6 are synthetic peptides that trigger growth hormone release by acting on the ghrelin receptor. Despite documented physiological activity, neither holds FDA approval, and both are prohibited by WADA under Category S2.
News WireWeightlifter Jara MacDermott accepted a two-year period of ineligibility on August 20, 2026, for testing positive for canrenone, amphetamine, and testosterone. The announcement arrives eight days after USADA publicly flagged BPC-157 as a.
News WireForensic analysis of peptides sold through Facebook Marketplace and Australia Post revealed empty vials, wildly inconsistent dosing, and trace heavy metals. Australia's TGA responded by elevating unapproved peptides to a priority.
News WireThe PCAC's July 23–24 votes to recommend BPC-157, Semax, and four other peptides for compounding eligibility override FDA scientists' unanimous opposition. Legal access still requires a rulemaking process with no set timeline.
News WireThe FDA advisory panel voted to recommend compounding access for two longevity peptides, Epitalon and MOTS-c, while its own staff argued the evidence was insufficient. New expert reviews lay out how far the science remains from the.
GuidePepsin and other enzymes dismantle peptides in the stomach within minutes. While oral semaglutide succeeds due to a specific permeation enhancer, standard capsules deliver negligible systemic exposure. This is the core challenge for any.
News WireSocial media celebrates the Wolverine Stack as a shortcut to rapid injury healing. Stanford Medicine and AMA experts counter that no controlled human trial has tested BPC-157 and TB-500 together, and the FDA's Category 2 designation bars.
GuideThe NCAA explicitly bans peptide hormones, growth factors, and related substances. This prohibition applies year-round. A positive test for BPC-157 or MK-677 results in a minimum one-year loss of eligibility, with very narrow exceptions.
GuideNot all peptides are legal in the United States. FDA-approved drugs like insulin are lawful, while unapproved compounds face strict compounding bans. Recent regulatory shifts have created a complex landscape where legality hinges on.
GuideFDA advisers voted to allow compounding pharmacies to produce six unapproved peptides. The decision overrides agency warnings that these products lack human trial data and carry risks of contamination and incorrect dosing.
News WireThe FDA's Pharmacy Compounding Advisory Committee voted 8-6 on July 23 to recommend placing BPC-157, TB-500, and other peptides on the agency's bulks list, a shift that follows years of promotion by Joe Rogan, RFK Jr., and wellness clinic.
News WireThe drugmaker is suing four online peptide sellers, a California med spa, and a compounding pharmacy for marketing an unapproved triple-receptor agonist to consumers under a 'research use' label.
News WireEli Lilly filed six federal lawsuits against compounding pharmacies, med spas, and online sellers marketing unapproved retatrutide as 'research-use only,' challenging a labeling convention the drugmaker says conceals illegal human.
GuideWhile semaglutide and insulin are approved drugs with validated safety data, peptides like BPC-157 and TB-500 are not. Understanding the difference between drug approval and compounding eligibility is critical for patient safety.
News WireAn FDA advisory panel narrowly recommended reclassifying four unapproved peptides from a prohibited-compounding category to one that permits licensed pharmacies to prepare them. The vote does not constitute drug approval, and formal.
News WireFDA staff scientists recommended against every peptide under review. The advisory panel voted six through anyway, citing grey-market harm. Formal rulemaking now determines whether compounding pharmacies gain legal access.
Guide\\\"Legal to sell and entirely unpoliced for quality,\\\" grey market peptides operate in a regulatory vacuum where \\\"research use only\\\" labels do not guarantee purity, sterility, or accurate dosing. Independent lab analyses have found endotoxin.
GuideResearch peptides sold for laboratory use have not been evaluated or approved by the FDA. Their scientific validity relies entirely on analytical purity and identity verification. A 2020 peer-reviewed review establishes that peptides.
News WireOn July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8-6, with one abstention, to recommend adding six peptides to the 503A compounding list, directly contradicting the agency's own scientific staff. The vote is.
News WireA narrowly composed FDA advisory panel recommended placing six unproven peptides into a category that permits pharmacy compounding, over the objections of career scientists. The vote follows HHS Secretary RFK Jr.'s personal advocacy and.
News WireMike McKnight told Cam Hanes' podcast audience that BPC-157 healed his herniated disc and let him cancel surgery. USADA prohibits the peptide at all times. The FDA just voted to let compounding pharmacies make it.
News WireThe USC gerontologist who identified MOTS-c is sounding the alarm on a thriving online trade that sells the mouse-exercise peptide to consumers without purity or sterility guarantees.
GuideOnly three injectable peptide therapies are currently FDA-approved for chronic weight management. This guide distinguishes regulatory status, clinical trial data, and safety profiles for approved therapies versus unregulated research.
GuideThe 'Wolverine Stack' has moved from online forums to physical exam rooms, with providers in Florida, Texas, and Connecticut marketing a combined BPC-157 and TB-500 protocol. While preclinical data supports individual tissue repair.